Anthony Mattacchione, Gerald Herman
Bruker said that Anthony Mattacchione will resign as chief financial officer and senior VP, effective Mar. 16, 2018. Mattacchione has accepted a position as CFO of Albany Molecular Research, commencing in April 2018. Gerald Herman, currently vice president and corporate controller at Bruker, will also serve as Bruker's principal accounting officer, effective immediately. Herman joined the firm in 2016 as VP and corporate controller. Prior to that, he served as corporate VP of clinical operations of Parexel from 2014 to February 2016, and before that, corporate VP of Parexel from 2008 to 2013. Herman has also served as VP-corporate controller of Presstek.